Alessandro Leonetti, D.C. (2021). A bug in the resistance to EGFR inhibitors: is there a role for Mycoplasma and cytidine deaminase in reducing the activity of osimertinib in lung cancer patients?. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 147(10), 3135-3137 [10.1007/s00432-021-03647-x].

A bug in the resistance to EGFR inhibitors: is there a role for Mycoplasma and cytidine deaminase in reducing the activity of osimertinib in lung cancer patients?

Daniela Carbone
Primo
;
2021-04-26

26-apr-2021
Alessandro Leonetti, D.C. (2021). A bug in the resistance to EGFR inhibitors: is there a role for Mycoplasma and cytidine deaminase in reducing the activity of osimertinib in lung cancer patients?. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 147(10), 3135-3137 [10.1007/s00432-021-03647-x].
File in questo prodotto:
File Dimensione Formato  
letter 2021.pdf

Solo gestori archvio

Tipologia: Versione Editoriale
Dimensione 781.97 kB
Formato Adobe PDF
781.97 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/521490
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact